CYP24A1 and hypercalcemia disease: The existing risk of severe hypercalcemia with high vitamin D bolus doses as it has been applied for rickets prevention in the UK in the 1950s or in Poland and former East Germany in the 1980s, in individuals with pathogenic CYP24A1 mutations, points towards caution with high dose vitamin D supplementation [33].